H. Gralnick

发表

Whole Body Hyperthermia: A Phase-l Trial of a Potential Adjuvant to Chemotherapy

T. Shawker, G. Bynum, W. Schuette, 1979 .

A model of fulminant hepatic failure in the rabbit

H. Gralnick, I. Kopin, P. Berk, 1978 .

Characteristics of blast crisis in chronic granulocytic leukemia.

H. Gralnick, V. Devita, G. Canellos, 1977, Blood.

Platelet adhesion at high shear rates: The roles of von Willebrand factor/GPIb and the β1 integrin α2β1

H. Gralnick, H. Krutzsch, L. Garfinkel, 1996 .

Pentosan‐induced thrombocytopenia: support for an immune complex mechanism

H. Gralnick, M. Horne, Kathryn E. Goad, 1994, British journal of haematology.

von Willebrand factor binds specifically to sulfated glycolipids.

H. Gralnick, D. Roberts, S. Williams, 1986, The Journal of biological chemistry.

Platelets Adhere to Sulfatides by von Willebrand Factor Dependent and Independent Mechanisms

H. Gralnick, D. Roberts, S. Williams, 1991, Thrombosis and Haemostasis.

Inhibition of platelet-von Willebrand factor binding to platelets by adhesion

H. Gralnick, H. Gralnick, R. Parker, 2011 .

Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.

H. Gralnick, H. Gralnick, S. Williams, 1990, The Journal of clinical investigation.

Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas.

H. Gralnick, H. Larjava, J. Uitto, 1989, The Journal of clinical investigation.

Abnormal coagulation results in patients with Hodgkin's disease.

D. Longo, H. Gralnick, V. Devita, 1985, The American journal of medicine.

A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations.

R. Schooley, H. Gralnick, A. Fauci, 1981, Blood.

A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations

R. Schooley, H. Gralnick, A. Fauci, 1981 .

Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study.

A. Quyyumi, H. Gralnick, N. P. Andrews, 1996, Journal of the American College of Cardiology.

Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein.

H. Gralnick, S. Williams, M. Rick, 1983, Proceedings of the National Academy of Sciences of the United States of America.

to MOPP Chemotherapy Bone Marrow Involvement in Hodgkin's Disease: Pathology and Response

H. Gralnick, B. Chabner, C. Myers, 2011 .

Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapy.

H. Gralnick, B. Chabner, C. Myers, 1974, Blood.

1‐desamino‐8‐arginine‐vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease

H. Gralnick, L. McKeown, P. Merryman, 1996, American journal of hematology.

Platelet activation and alpha granule secretion in type IIB von Willebrand's disease

H. Gralnick, B. Shafer, L. McKeown, 1991, British journal of haematology.

DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times.

G. Marti, H. Gralnick, M. Rick, 1986, Blood.

Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro.

H. Gralnick, J. Uitto, J. Peltonen, 1991, The Journal of clinical investigation.

Collagen, and Laminin in Human Skin Variable Expression in Basal and Squamous Cell Carcinomas

Kenneth M. Yamada, H. Gralnick, H. Larjava, 1989 .

Physiologic manifestations of human anaphylaxis.

P. L. Smith, E. Bleecker, H. Gralnick, 1980, The Journal of clinical investigation.

The Idiopathic Hypereosinophilic Syndrome

H. Gralnick, W. Roberts, V. Ferrans, 2020 .

Inhibition of experimental metastasis of human breast-carcinoma cells in athymic nude-mice by anti-alpha(5)beta(1) fibronectin receptor integrin antibodies.

H. Gralnick, K. Olden, K. Yamada, 1995, International journal of oncology.

Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome.

H. Gralnick, J. Harley, A. Fauci, 1983, The American journal of cardiology.

Studies on the Factor VIII/von Willebrand factor antigen on human platelets.

H. Gralnick, B. Coller, R. Hirschman, 1975, Thrombosis research.

Frequencies and patterns of bone marrow involvement in non‐hodgkin lymphomas: Observations on the value of bilateral biopsies

H. Gralnick, B. Coller, B. Chabner, 1977, American journal of hematology.

Physiologic Manifestations of Human Anapf is

E. Bleecker, H. Gralnick, R. Traystman, 1980 .

Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids.

L. Liotta, H. Gralnick, C. N. Rao, 1986, The Journal of biological chemistry.

Normal human blood density gradient lymphocyte subset analysis: I. An interlaboratory flow cytometric comparison of 85 normal adults

G. Marti, H. Gralnick, P. Horan, 1985, American journal of hematology.

A new mechanism of exogenous hyperglyceridemia.

H. Gralnick, C. Glueck, D. Fredrickson, 1969, Annals of internal medicine.

Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance.

H. Gralnick, C. Glueck, D. Fredrickson, 1969, The American journal of medicine.

MYELODYSPLASTIC SYNDROMES: IS ANOTHER CLASSIFICATION NECESSARY?

H. Gralnick, D. Catovsky, G. Flandrin, 1984, British journal of haematology.

The hemostatic response to open-heart operations.

H. Gralnick, R. Fischer, R. Fischer, 1971, The Journal of thoracic and cardiovascular surgery.

Treatment of polyneuropathy in Waldenström's macroglobulinemia

W. Engel, H. Gralnick, M. Dalakas, 1983, Neurology.

A preliminary analysis of platelet von Willebrand factor oligosaccharides.

H. Gralnick, S. Williams, M. Horne, 2000, Nagoya journal of medical science.

Purification and characterization of human platelet von Willebrand factor

H. Gralnick, H. Krutzsch, L. McKeown, 1994, British journal of haematology.

Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease

H. Gralnick, Y. Sultan, R. Parker, 1986 .

Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.

H. Gralnick, B. Coller, S. Williams, 1984, Blood.

Commentary: a new classification for von Willebrand disease.

H. Gralnick, J. Sadler, Harvey R. Gralnick, 1994, Blood.

Platelet adhesion to collagen in individuals lacking glycoprotein IV.

H. Gralnick, S. Williams, L. McKeown, 1994, Blood.

Multiple childhood osteosarcomas in an american indian family with erythroid macrocytosis and skeletal anomalies

J. Whang‐Peng, H. Gralnick, J. Mulvihill, 1977, Cancer.

Gamma-interferon modulates von Willebrand factor release by cultured human endothelial cells.

H. Gralnick, S. Tannenbaum, 1990, Blood.

Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine.

H. Gralnick, A. Fauci, J. Kovacs, 1988, Annals of internal medicine.

Platelet freeze-storage for antibody testing.

H. Gralnick, R. Hirschman, 1975, Thrombosis research.

A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE.

H. Gralnick, R. Hirschman, 1974, The Journal of laboratory and clinical medicine.

Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.

H. Gralnick, B. Coller, Y. Sultan, 1976, Science.

Breast hemangiomas in a patient with Kasabach-Merritt syndrome: imaging findings.

H. Gralnick, S. Hill, N. Courcoutsakis, 1997, AJR. American journal of roentgenology.

Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

H. Gralnick, Elinor Abrell, 1973, British journal of haematology.

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival.

H. Gralnick, V. Devita, P. Banks, 1975, The American journal of medicine.

A method to average immunofluorescent histograms.

G. Marti, W. Schuette, H. Gralnick, 1986, Cytometry.

Endogenous platelet fibrinogen: its modulation after surface expression is related to size‐selective access to and conformational changes in the bound fibrinogen

H. Gralnick, B. Shafer, L. McKeown, 1992, British journal of haematology.

Platelet von Willebrand factor.

H. Gralnick, S. Williams, R. Parker, 1991, Mayo Clinic proceedings.

Platelet von Willebrand factor: comparison with plasma von Willebrand factor.

H. Gralnick, S. Williams, M. Rick, 1985, Thrombosis research.

The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.

H. Gralnick, B. Coller, B. R. Franza, 1976, Blood.

Sensitive Methods for the Detection and Characterization of Platelet Isoantibodies

H. Gralnick, B. Coller, R. Yankee, 1973, Thrombosis and Haemostasis.

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations.

H. Gralnick, V. Devita, P. Banks, 1975, The American journal of medicine.

Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.

J. Bull, H. Gralnick, E. Henderson, 1974, Transplantation proceedings.

Bone-marrow biopsy in Hodgkin's disease.

H. Gralnick, V. Devita, J. Bennett, 1968, The New England journal of medicine.

Flow cytometric analysis of platelet surface antigens.

G. Marti, H. Gralnick, W. Schuette, 1988, Cytometry.

Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis.

H. Gralnick, H. K. Tan, 1974, Human pathology.

Plasma and platelet von Willebrand factor defects in uremia.

H. Gralnick, S. Williams, B. Shafer, 1988, The American journal of medicine.

ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIA

H. Gralnick, C. Sultan, 1975, British journal of haematology.

associated correction of prolonged bleeding times DDAVP infusion in five patients with type Ia glycogen storage disease and

G. Marti, H. Gralnick, M. Rick, 2013 .

von Willebrand factor release induced by endotoxin.

H. Gralnick, S. Williams, R. Elin, 1989, The Journal of laboratory and clinical medicine.

Thrombosis with epsilon aminocaproic acid therapy.

H. Gralnick, P. Greipp, 1971, American journal of clinical pathology.

Intravascular coagulation. 2. Underlying conditions and therapy.

H. Gralnick, 1977, Postgraduate medicine.

∈-AMINOCAPROIC ACID IN PREOPERATIVE CORRECTION OF HÆMOSTATIC DEFECT IN CYANOTIC CONGENITAL HEART-DISEASE

H. Gralnick, 1970 .

time in type I von Willebrand's disease Platelet von Willebrand factor: an important determinant of the bleeding

H. Gralnick, Y. Sultan, R. Parker, 2011 .

Platelet von Willebrand Factor : An Important Determinant of the Bleeding Time in Type I von Willebrand ’ s Disease

H. Gralnick, S. Williams, Y. Sultan, 2005 .

Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A.

H. Gralnick, B. Coller, S. Marchesi, 1975, Thrombosis research.

Effects of autotransfusion on blood elements.

H. Gralnick, G. Geelhoed, R. Hoye, 1973, American journal of surgery.

Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.

H. Gralnick, 1970, Lancet.

Defibrination in acute pancreatitis.

H. Gralnick, P. Greipp, J. A. Brown, 1972, Annals of internal medicine.

von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.

H. Gralnick, A. Nurden, G. Vezon, 1992, Blood.

The hemostatic imbalance of plasma-exchange transfusion.

W. Engel, H. Gralnick, F. Appelbaum, 1979, Blood.

Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.

H. Gralnick, B. Coller, B S Coller, 1977, The Journal of clinical investigation.

Acquired hypoprothrombinemia: Effects of Danazol® treatment

H. Gralnick, P. Comp, Sybil B. Williams, 1996, American journal of hematology.

MOLECULAR DEFECTS IN HÆMOPHILIA A AND VON WILLEBRAND'S DISEASE

H. Gralnick, B. Coller, H. Gralnick, 1976, The Lancet.

Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.

H. Gralnick, B. Coller, Y. Sultan, 1975, The Journal of clinical investigation.

Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein.

H. Gralnick, B. Coller, 1975, Blood.

Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.

H. Gralnick, R. Milton, B. Coller, 1978, Annals of internal medicine.

Immunological studies of factor VIII in haemophilia and von Willebrand's disease.

H. Gralnick, B. Coller, S. Marchesi, 1973, Nature: New biology.

IgA inhibitor to factor VIII/von Willebrand factor

H. Gralnick, B. Coller, C. Kessler, 1985, British journal of haematology.

Platelet aggregation induced by type IIb platelet von Willebrand factor

H. Gralnick, Y. Sultan, L. McKeown, 1989, British journal of haematology.

A variant of type II von willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von willebrand factor structure

H. Gralnick, Y. Sultan, P. Maisonneuve, 1987, American journal of hematology.

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)

H. Gralnick, D. Catovsky, G. Flandrin, 1991, British journal of haematology.

NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

H. Gralnick, W. Roberts, V. Ferrans, 1982, Annals of internal medicine.

Coombs' positive reactions associated with sodium cephalothin therapy.

H. Gralnick, M. Mcginniss, L. D. Wright, 1967, JAMA.

Classification of Acute Leukemia

D. A. G. Galton, John M. Bennett, H. Gralnick, 1977 .

A model of fulminant hepatic failure in the rabbit.

H. Gralnick, I. Kopin, P. Berk, 1978, Gastroenterology.

Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration.

W. T. Chen, H. Gralnick, K. Yamada, 1990, Cancer research.

Small F chromosome in myelo- and lymphoproliferative diseases

J. Whang‐Peng, H. Gralnick, H. Brereton, 1977 .

The Chediak-Higashi syndrome: continuous suspension cultures derived from peripheral blood.

H. Gralnick, A. Haase, S. Wolff, 1969, Blood.

Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure.

H. Gralnick, L. Corash, H. Tan, 1977, Blood.

Coagulation disorders in cancer.

H. Gralnick, Kathryn E. Goad, K. Goad, 1996, Hematology/oncology clinics of North America.

Factor VIII/Von Willebrand Factor Protein Sensitivity Of Periodic Acid Schiff Stain To Carbohydrate Deficiency

H. Gralnick, S. Williams, G. Jackson, 1982, Thrombosis and Haemostasis.

Von Willebrand's disease: combined qualitative and quantitative abnormalities.

H. Gralnick, B. Coller, Y. Sultan, 1977, The New England journal of medicine.

Novel function for beta 1 integrins in keratinocyte cell-cell interactions

H. Gralnick, H. Larjava, J. Uitto, 1990, The Journal of cell biology.

Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics.

J. Whang‐Peng, H. Gralnick, R. Johnson, 1974, Blood.

The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations

H. Gralnick, D. Catovsky, J. Bennett, 1981, British journal of haematology.

Polyclonal B‐cell lymphocytosis and hypergammaglobulinemia in patients with gaucher disease

G. Marti, H. Gralnick, M. Rick, 1988, American journal of hematology.

High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains.

H. Gralnick, H. Krutzsch, S. Williams, 1994, Proceedings of the National Academy of Sciences of the United States of America.

High-affinity a-thrombin binding to platelet glycoprotein Iba : Identification of two binding domains ( hombods / bood cgt )

H. Gralnick, J. Fenton, L. McKeown, 2022 .

A VARIANT FORM OF HYPERGRANULAR PROMYELOCYTIC LEUKAEMIA (M3)

H. Gralnick, D. Catovsky, J. Bennett, 1980, British journal of haematology.

Development of myeloblastoma with massive breast and ovarian involvement during remission in acute leukemia

H. Gralnick, Klaus Djttmar, 1969, Cancer.

Myelofibrosis in chronic granulocytic leukemia.

H. Gralnick, C. Vogel, J. Harbor, 1971, Blood.

Ultrastructural studies in acute promyelocytic leukemia.

H. Gralnick, H. K. Tan, B. Wages, 1972, Blood.

Radiation‐induced remissions in chronic lymphocytic leukemia

H. Gralnick, A. Kagan, Ralph E. Johnson, 1967, Cancer.

Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.

J. Whang‐Peng, H. Gralnick, G. Canellos, 1977, The American journal of medicine.

Immune Cross-reactivity of Penicillin and Cephalothin

H. Gralnick, M. Mcginniss, MARY H. MCGINNISS, 1967, Nature.

Diffuse osteosclerosis in hairy cell leukemia.

D. Longo, H. Gralnick, W. Urba, 1989, Blood.

Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha.

E. Jaffe, H. Gralnick, H. Young, 1988, Blood.

Hemolytic anemia associated with cephalothin.

H. Gralnick, M. Mcginniss, P. McCurdy, 1971, JAMA.

Thrombocytopenia with sodium cephalothin therapy.

H. Gralnick, M. Mcginniss, R. Halterman, 1972, Annals of internal medicine.

Glycocalicin levels in the plasma of HIV+ patients: an indicator of platelet turnover.

H. Gralnick, S. Williams, R. Yarchoan, 1998, The Journal of laboratory and clinical medicine.

Altered processing of integrin receptors during keratinocyte activation.

H. Gralnick, K. Yamada, F. Grinnell, 1991, Experimental cell research.

Asialo von Willebrand factor binding to and aggregation of platelets: effects of inhibitors of platelet metabolism and function.

H. Gralnick, S. Williams, L. McKeown, 1987, Journal of Laboratory and Clinical Medicine.

Effects of Vancomycin on Platelets, Plasma Proteins and Hepatitis B Surface Antigen

H. Gralnick, B. Coller, W. B. Lundberg, 1975, Thrombosis and Haemostasis.

Conformational Regulation of the Fibronectin Binding and α3β1 Integrin-mediated Adhesive Activities of Thrombospondin-1*

H. Gralnick, D. Roberts, N. Templeton, 2001, The Journal of Biological Chemistry.

Hypofibrinogenemia and coagulation factor deficiencies with L‐asparaginase treatment

H. Gralnick, Edward S. Henderson, Harvey R. Gralnick, 1971, Cancer.

The staging of Hodgkin's disease.

H. Gralnick, M. Cohen, J. Bennett, 1968, Revue francaise d'etudes cliniques et biologiques.

Acute megakaryoblastic leukemia in childhood

E. Jaffe, J. Whang‐Peng, H. Gralnick, 1984, Cancer.

A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations.

R. Schooley, H. Gralnick, A. Fauci, 1981, Blood.

BONE MARROW TRANSPLANTATION FROM HL‐A‐MATCHED DONORS TO PATIENTS WITH ACUTE LEUKEMIA TOXICITY AND ANTILEUKEMIC EFFECT

H. Gralnick, E. Henderson, P. Terasaki, 1972, Transplantation.

Multicenter Comparison of von Willebrand Factor Multimer Sizing Techniques

H. Gralnick, P. Mannucci, E. Tuddenham, 1985, Thrombosis and Haemostasis.

A monomeric von Willebrand factor fragment, Leu-504-Ser-728, inhibits von Willebrand factor interaction with glycoprotein lb-IX

H. Gralnick, H. Krutzsch, M. Gorecki, 2022 .

Novel Function for Integrins in Keratinocyte Cell-Cell Interactions

Kenneth M. Yamada, H. Gralnick, H. Larjava, 2002 .

Acquired coagulation factor deficiencies in leukemia

H. Gralnick, Edward S. Henderson, 1970, Cancer.

Increased Expression of α4β1 and α5β1 Integrins on HTLV-I-Infected Lymphocytes

H. Gralnick, P. Klotman, A. Notkins, 1993 .

Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1.

H. Gralnick, D. Roberts, N. Templeton, 2001, The Journal of biological chemistry.

THEORETICAL APPROACH TO MOLECULAR BIOLOGY OF FACTOR VIII: HETEROGENEITY OF THE MOLECULE

H. Gralnick, B. Coller, S. Marchesi, 1975, Annals of the New York Academy of Sciences.

Osteosarcoma. Improved Survival with Anticoagulation and Amputation

H. Gralnick, A. Ketcham, H. Hoover, 1978 .

Hemostatic toxicity of Poly I-C.

H. Gralnick, E. Homan, R. Zendzian, 1972, Toxicology and applied pharmacology.

Nuclear topography in the abnormal cell of Sézary syndrome: observation by freeze-etch electron microscopy.

H. Gralnick, H. K. Tan, M. Harrison, 1974, Journal of the National Cancer Institute.

Alpha granule proteins in type I von Willebrand's disease

H. Gralnick, B. Shafer, L. McKeown, 1993, American journal of hematology.

Platelet to leukocyte adherence phenomena associated with thrombocytopenia.

H. Gralnick, P. Greipp, 1976, Blood.

Endogenous platelet fibrinogen surface expression on activated platelets.

H. Gralnick, S. Williams, J. Fenton, 1991, The Journal of laboratory and clinical medicine.

Glycocalicin derived peptides inhibit von Willebrand factor binding to platelets.

H. Gralnick, H. Krutzsch, S. Williams, 1997, Thrombosis research.

Hematologic abnormalities in fibrogenesis imperfecta ossium.

H. Gralnick, D. Golde, P. Greipp, 1971, The Journal of bone and joint surgery. American volume.

The effect of stir bar size and shape on quantitative platelet aggregation.

H. Gralnick, B. Coller, 1976, Thrombosis research.

Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

H. Gralnick, D. Catovsky, J. Bennett, 1976, British journal of haematology.

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group

H. Gralnick, D. Catovsky, J. Bennett, 1994, British journal of haematology.

Proposals for the classification of the myelodysplastic syndromes

H. Gralnick, D. Catovsky, J. Bennett, 1982, British journal of haematology.

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

H. Gralnick, D. Catovsky, J. Bennett, 1989, Journal of clinical pathology.

Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.

H. Gralnick, H. Gralnick, E. Abrams, 1978, The New England journal of medicine.

A variant form of hypergranular promyelocytic leukemia (M3)

H. Gralnick, D. Catovsky, J. Bennett, 1980, Annals of internal medicine.

Acute nonlymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia: Clinical studies

H. Gralnick, H. Brereton, F. Greco, 1979, Cancer.

The carbohydrate of human thrombin: structural analysis of glycoprotein oligosaccharides by mass spectrometry.

H. Gralnick, H. Gralnick, M. Horne, 1983, Archives of biochemistry and biophysics.

Activated platelets in paroxysmal nocturnal haemoglobinuria

H. Gralnick, H. Gralnick, L. McKeown, 1995, British journal of haematology.

Human Tumor Cell Migration Monoclonal Antibody and Synthetic Peptide Inhibitors of Updated Version

Kenneth M. Yamada, H. Gralnick, S. Yamada, 2006 .

Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease.

H. Gralnick, Y. Sultan, R. Parker, 1986, Blood.

Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease.

H. Gralnick, S. Williams, M. Cregger, 1982, Blood.

Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function.

H. Gralnick, H. Gralnick, J. Lawrence, 1987, Blood.

Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.

H. Gralnick, H. Gralnick, R. Parker, 1989, Blood.

Cancer Cell Procoagulant Activity

H. Gralnick, 1979, Thrombosis and Haemostasis.

Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.

H. Gralnick, S. Williams, L. Corash, 1982, Blood.

Plasma glycocalicin in platelet concentrates: relationship to other parameters of the storage lesion.

H. Gralnick, S. Williams, M. Sano, 1998, Thrombosis research.

Platelet von Willebrand factor in Hermansky‐Pudlak syndrome

H. Gralnick, W. Gahl, M. Rick, 1998, American journal of hematology.